Protein– tag –
-
Lipid Nanoparticles (LNP) Establish Success in COVID-19 Vaccines as Cutting-Edge Technology Essential for mRNA, siRNA Delivery
Inside Therapeutics International Overview Lipid nanoparticles (LNPs) are a cutting-edge nano-drug delivery system designed to protect and efficiently deliver nucleic acids, particularly mRNA and siRNA, to target cells. Through the succe... -
Vivici Expands High-Purity Lactoferrin Production via Precision Fermentation, Delivering Animal-Free Nutritional Quality and Functionality
Vivici Netherlands Overview Vivici is advancing scalable production of lactoferrin, a rare bioactive protein, through precision fermentation technology. This approach enables access to high-purity lactoferrin without animal reliance, enh... -
All G Unveils Bovine-Free Lactoferrin in U.S. via Precision Fermentation, Establishing Multi-Ton Annual Production Capacity
foodnavigator-usa.com USA Overview All G has announced the launch of bovine-free lactoferrin in the U.S. market, produced using precision fermentation technology, with human-identical protein launch imminent. The company has partnered wi... -
ADM and The EVERY Company Partner to Scale Commercial Production of Precision-Fermented Egg Protein OvoPro, Transforming the Future of Food
flavorist.com USA Overview ADM and The EVERY Company announced a strategic partnership to accelerate commercial-scale production of OvoPro, EVERY's flagship precision-fermented egg protein. This collaboration combines EVERY's proprietary... -
Precision Fermentation Drives Next-Gen Food Innovation: MycoTechnology Unveils Honey Truffle Sweet Protein, All G Launches Cow-Free Lactoferrin in US
foodingredientsfirst.com / Precision Fermentation News / flavorist.com / Vivici / Microbio International Overview Precision fermentation is significantly advancing the next-generation food ingredient market. MycoTechnology announced its ... -
Argonne National Lab’s ‘OPAL’ Integrates AI and Robotics for Autonomous Protein Design and Biomanufacturing, Strengthening Supply Chains
Argonne National Laboratory (DOE) USA Overview Argonne National Laboratory is developing the 'Orchestrated Platform for Autonomous Laboratories (OPAL),' an AI-driven protein design and humanoid robotics integration. This autonomous 'desi... -
Molecular Glue Development Accelerates: Gluetacs and Degron Advance Key Programs in Targeted Protein Degradation
GlobeNewswire Global Overview The field of molecular glues, a powerful targeted protein degradation (TPD) modality, is rapidly expanding with two significant clinical advancements: Gluetacs Therapeutics has initiated a Phase II trial for... -
Agentic and Generative AI to Revolutionize Cardiovascular Drug Discovery
American Heart Association Journals USA Overview Large Language Models (LLMs) and agentic AI are poised to fundamentally transform cardiovascular disease (CVD) drug development by enhancing target understanding, accelerating novel compou... -
Kymera Therapeutics’ Oral STAT6 Degrader KT-621 Shows Positive Phase 1b Atopic Dermatitis Data, Potential Injectable Alternative
TradingView Global Overview Kymera Therapeutics' lead candidate, KT-621 (an oral STAT6 degrader leveraging targeted protein degradation), demonstrated positive Phase 1b data in atopic dermatitis. Presented at the American Academy of Derm... -
Non-Endocytic Membrane-Translocating Delivery Strategies Bypass Endosomal Barriers for Gene, mRNA, and Protein Therapies
Drug Target Review UK Overview A new review evaluates non-endocytic membrane-translocating delivery strategies designed to circumvent insufficient endosomal escape efficiency, a major hurdle for many next-generation therapeutics. These e...
